1. Home
  2. BGLC vs STSS Comparison

BGLC vs STSS Comparison

Compare BGLC & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • STSS
  • Stock Information
  • Founded
  • BGLC 2017
  • STSS 2017
  • Country
  • BGLC Malaysia
  • STSS United States
  • Employees
  • BGLC N/A
  • STSS N/A
  • Industry
  • BGLC Medical Specialities
  • STSS Medical/Dental Instruments
  • Sector
  • BGLC Health Care
  • STSS Health Care
  • Exchange
  • BGLC Nasdaq
  • STSS Nasdaq
  • Market Cap
  • BGLC 5.0M
  • STSS 5.5M
  • IPO Year
  • BGLC N/A
  • STSS 2022
  • Fundamental
  • Price
  • BGLC $2.71
  • STSS $5.53
  • Analyst Decision
  • BGLC
  • STSS
  • Analyst Count
  • BGLC 0
  • STSS 0
  • Target Price
  • BGLC N/A
  • STSS N/A
  • AVG Volume (30 Days)
  • BGLC 69.9K
  • STSS 2.7M
  • Earning Date
  • BGLC 08-13-2025
  • STSS 08-13-2025
  • Dividend Yield
  • BGLC N/A
  • STSS N/A
  • EPS Growth
  • BGLC N/A
  • STSS N/A
  • EPS
  • BGLC N/A
  • STSS N/A
  • Revenue
  • BGLC $9,265,870.00
  • STSS N/A
  • Revenue This Year
  • BGLC N/A
  • STSS N/A
  • Revenue Next Year
  • BGLC N/A
  • STSS N/A
  • P/E Ratio
  • BGLC N/A
  • STSS N/A
  • Revenue Growth
  • BGLC N/A
  • STSS N/A
  • 52 Week Low
  • BGLC $2.01
  • STSS $3.36
  • 52 Week High
  • BGLC $8.40
  • STSS $2,224.20
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 43.64
  • STSS 43.41
  • Support Level
  • BGLC $2.60
  • STSS $5.15
  • Resistance Level
  • BGLC $3.06
  • STSS $5.83
  • Average True Range (ATR)
  • BGLC 0.21
  • STSS 0.46
  • MACD
  • BGLC -0.06
  • STSS 0.41
  • Stochastic Oscillator
  • BGLC 16.27
  • STSS 32.28

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.

Share on Social Networks: